Cargando…
Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction
PURPOSE OF REVIEW: Subcutaneous adipose tissue (SAT) is often described as ‘protective’. Visceral adipose tissue (VAT) is often described as ‘pathologic’. However, both SAT and VAT have protective and pathologic potential, with interdependent biologic functions. RECENT FINDINGS: Most of the body...
Autor principal: | Bays, Harold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154790/ https://www.ncbi.nlm.nih.gov/pubmed/25106000 http://dx.doi.org/10.1097/MED.0000000000000093 |
Ejemplares similares
-
Testosterone and weight loss: the evidence
por: Traish, Abdulmaged M.
Publicado: (2014) -
Adiposopathy, “Sick Fat,” Ockham’s Razor, and Resolution of the Obesity Paradox
por: Bays, Harold
Publicado: (2014) -
Is adiposopathy (sick fat) an endocrine disease?
por: Bays, H E, et al.
Publicado: (2008) -
Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease?
por: Bays, H E, et al.
Publicado: (2009) -
Contribution of markers of adiposopathy and adipose cell size in predicting insulin resistance in women of varying age and adiposity
por: Tremblay, Eve-Julie, et al.
Publicado: (2022)